| [1] | Huang Shan, Zhou Hao, Chen XueLing, Yao Xin, Tang ShanHong, Yang GuoDong, Qin JianPing. Effect of transjugular intrahepatic portosystemic shunt on the liver and the heart[J]. Journal of Clinical Hepatology, 2020, 36(4): 904-907. doi: 10.3969/j.issn.1001-5256.2020.04.043 |
| [2] | Jiang Zhao, Ruan Bo. The role of liver sinusoidal endothelial cells in the progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(3): 684-686. doi: 10.3969/j.issn.1001-5256.2020.03.047 |
| [3] | Wang Li, Qiu YiLing, Wang JianShe. Advances in research and application of liver organoids[J]. Journal of Clinical Hepatology, 2019, 35(10): 2342-2345. doi: 10.3969/j.issn.1001-5256.2019.10.047 |
| [4] | Chen YangYi, Liu ChengHai. Development and prospects of pathological classification systems for chronic hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(5): 1098-1102. doi: 10.3969/j.issn.1001-5256.2018.05.037 |
| [5] | Tian AiPing, Yang YongFeng. A comparative analysis of pathological grading and staging systems for chronic hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2271-2277. doi: 10.3969/j.issn.1001-5256.2018.11.002 |
| [6] | Sun Jing, Wang JingYun, Li QingQuan, Lu: MeiDe, Gao YanHang. Successful treatment of thrombocytopenia associated with chronic viral hepatitis: a report of two cases and literature review[J]. Journal of Clinical Hepatology, 2015, 31(2): 275-277. doi: 10.3969/j.issn.1001-5256.2015.02.032 |
| [7] | Expert Committee on Clinical Management of Adverse Reactions in Interferon-α Therapy for Chronic Viral Hepatitis . Expert consensus on clinical management of adverse reactions in interferon-α therapy for chronic viral hepatitis[J]. Journal of Clinical Hepatology, 2014, 30(11): 1106-1111. doi: 10.3969/j.issn.1001-5256.2014.11.003 |
| [8] | Qin Hua, Wang WenZheng, Wang ZhanLan. Significance of ICGR15 and EHBF in evaluating liver reserve function among patients with chronic hepatitis[J]. Journal of Clinical Hepatology, 2014, 30(2): 141-144. doi: 10.3969/j.issn.1001-5256.2014.02.011 |
| [9] | Yang HaiFeng, Xue Ling, Miao YiHui, Zheng CaiJuan, Yao ZuoYi, Zhang YanShu, Yao Lin. Expression and significance of caspase-8 in chronic hepatitis [J]. Journal of Clinical Hepatology, 2013, 29(2): 138-141. |
| [10] | Yao XiXian, Yao DongMei. Combination treatment of Chinese traditional and Western medicine in chronic hepatitis and liver fibrosis[J]. Journal of Clinical Hepatology, 2013, 29(4): 245-248+252. |
| [11] | Zhang JiMing, Mao WenShan. A case report of hepatic tuberculosis misdiagnosed as chronic hepatitis [J]. Journal of Clinical Hepatology, 2012, 28(11): 867-867. |
| [12] | Zhang XiuNa, Wang JunYu, Gao PuJun. Correlation of quantitative analysis of chronic hepatitis,nephritic syndrome,ascites and serum albumin[J]. Journal of Clinical Hepatology, 2012, 28(1): 33-34+47. |
| [13] | Gao BaoXiu, He Yong, Li GuiXing, Nie Xin, Luo TongXing, Song HaoLan. Analysis of relationship of chronic severe hepatitis with hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2011, 27(7): 749-751. |
| [14] | Cai WeiMin. Some problems in anti-fibrotic therapies[J]. Journal of Clinical Hepatology, 2011, 27(3): 225-232. |
| [15] | Hu Bo, Cheng Juan, Ban XiangFang. A rare case of congenital malformation of liver development[J]. Journal of Clinical Hepatology, 2011, 27(6): 662-662. |
| [16] | Luo Ming, Cao WuKui. Research progress on microbial modulators in treatment of severe hepatitis with endotoxemia[J]. Journal of Clinical Hepatology, 2011, 27(7): 775-778. |
| [17] | Gu XiBing, Yang XiaoJuan, Zhu HongYing, Xu YueQin. Effect of medical ozone therapy in the hepatorenal syndrome in patients with chronic severe hepatitis[J]. Journal of Clinical Hepatology, 2010, 26(6): 598-601. |
| [20] | Liu Wei, Zhao Wei, Luo Chan, Ceng WenQuan. To study the detection of HBVDNA in the liver tissues and serum of the patients with hepatitis virus B.[J]. Journal of Clinical Hepatology, 2005, 21(1): 12-13. |
DownLoad: